Securities code: 300942 securities abbreviation: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) Announcement No.: 2022-008 Shenzhen Bioeasy Biotechnology Co.Ltd(300942)
Announcement on re recognition of high-tech enterprises
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) (hereinafter referred to as “the company”) recently received the certificate of high tech enterprise jointly issued by Shenzhen Science and technology innovation Commission, Shenzhen finance bureau, State Administration of Taxation and Shenzhen Taxation Bureau. The details are as follows:
Certificate No.: gr202144206881
Issued on: December 23, 2021
Period of validity: three years
This recognition is the re recognition of the company after the expiration of the original high-tech enterprise certificate. According to the relevant provisions of the state, the company can continue to enjoy the preferential tariff policies of the state on high-tech enterprises for three consecutive years (2021-2023) from the re recognition of high-tech enterprises. The re recognition of the high-tech enterprise certificate is a full affirmation of the company’s technical strength and R & D level, which is conducive to reducing the enterprise tax burden and will play a positive role in promoting the operation and development of the company.
It is hereby announced.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) board of directors February 16, 2022
